ZNF461
gene geneOn this page
Also known as GIOT-1MGC33911
Summary
ZNF461 (zinc finger protein 461, HGNC:21629) is a protein-coding gene on chromosome 19q13.13, encoding Zinc finger protein 461 (Q8TAF7). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 92283 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_153257
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21629 |
| Approved symbol | ZNF461 |
| Name | zinc finger protein 461 |
| Location | 19q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GIOT-1, MGC33911 |
| Ensembl gene | ENSG00000197808 |
| Ensembl biotype | protein_coding |
| OMIM | 608640 |
| Entrez | 92283 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 4 protein_coding, 3 nonsense_mediated_decay, 3 protein_coding_CDS_not_defined, 2 retained_intron
ENST00000360357, ENST00000396893, ENST00000540605, ENST00000588268, ENST00000588844, ENST00000589442, ENST00000590361, ENST00000590487, ENST00000591370, ENST00000591827, ENST00000592496, ENST00000592829
RefSeq mRNA: 8 — MANE Select: NM_153257
NM_001297623, NM_001322821, NM_001322823, NM_001322825, NM_001322826, NM_001322827, NM_001322828, NM_153257
CCDS: CCDS54257, CCDS74348
Canonical transcript exons
ENST00000588268 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001526631 | 36666690 | 36666837 |
| ENSE00002913857 | 36636618 | 36640043 |
| ENSE00003506703 | 36664698 | 36664786 |
| ENSE00003593322 | 36658299 | 36658425 |
| ENSE00003675166 | 36643794 | 36643862 |
| ENSE00003787713 | 36656448 | 36656543 |
Expression profiles
Bgee: expression breadth ubiquitous, 160 present calls, max score 84.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.4126 / max 132.9588, expressed in 1550 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180688 | 5.4126 | 1550 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 84.08 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 82.19 | gold quality |
| cerebellar cortex | UBERON:0002129 | 82.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.68 | gold quality |
| ventricular zone | UBERON:0003053 | 81.49 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.48 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.10 | gold quality |
| adrenal tissue | UBERON:0018303 | 80.58 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.32 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.11 | gold quality |
| cerebellum | UBERON:0002037 | 79.78 | gold quality |
| calcaneal tendon | UBERON:0003701 | 79.70 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.90 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 78.16 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.06 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 78.04 | gold quality |
| monocyte | CL:0000576 | 77.88 | gold quality |
| popliteal artery | UBERON:0002250 | 77.65 | gold quality |
| tibial artery | UBERON:0007610 | 77.65 | gold quality |
| leukocyte | CL:0000738 | 77.62 | gold quality |
| right frontal lobe | UBERON:0002810 | 77.32 | gold quality |
| mucosa of stomach | UBERON:0001199 | 77.24 | gold quality |
| left adrenal gland | UBERON:0001234 | 77.23 | gold quality |
| right adrenal gland | UBERON:0001233 | 77.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.17 | gold quality |
| sural nerve | UBERON:0015488 | 77.07 | gold quality |
| bone marrow cell | CL:0002092 | 77.02 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.01 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.00 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 76.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.70 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
3 targets.
| Target | Regulation |
|---|---|
| CYP19A1 | Repression |
| NR5A2 | Repression |
| SF1 |
Upstream regulators (CollecTRI, top): CREB1, NR0B1, NR4A1, NR5A1
miRNA regulators (miRDB)
67 targeting ZNF461, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-4739 | 99.84 | 65.25 | 1832 |
| HSA-MIR-4756-5P | 99.84 | 64.98 | 1809 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
Literature-anchored findings (GeneRIF, showing 1)
- Molecular cloning and tissue distribution of ZNF461. (PMID:15004467)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 461 — Q8TAF7 (reviewed: Q8TAF7)
Alternative names: Gonadotropin-inducible ovary transcription repressor 1
All UniProt accessions (7): B4DRP8, Q8TAF7, K7EIW1, K7EJM1, K7EKL0, K7ESQ5, X6RBI5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Widely expressed, with highest levels in liver, kidney, pancreas, thymus, and small intestine.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TAF7-1 | 1 | yes |
| Q8TAF7-2 | 2 |
RefSeq proteins (8): NP_001284552, NP_001309750, NP_001309752, NP_001309754, NP_001309755, NP_001309756, NP_001309757, NP_694989* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (16 total): zinc finger region 12, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TAF7-F1 | 65.14 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 68 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ALKBH3_TARGET_GENES, DIDO1_TARGET_GENES, GLI4_TARGET_GENES, RYBP_TARGET_GENES, ZIM3_TARGET_GENES, ZNF274_TARGET_GENES, ZNF30_TARGET_GENES, ZNF329_TARGET_GENES, ZNF350_TARGET_GENES, ZNF502_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
476 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF461 | TOX2 | Q96NM4 | 923 |
| ZNF461 | PHGDH | O43175 | 687 |
| ZNF461 | LIME1 | Q9H400 | 602 |
| ZNF461 | SLA2 | Q9H6Q3 | 601 |
| ZNF461 | LGALS4 | P56470 | 505 |
| ZNF461 | DEFB4A | O15263 | 466 |
| ZNF461 | DEPDC4 | Q8N2C3 | 418 |
| ZNF461 | CEP57L1 | Q8IYX8 | 378 |
| ZNF461 | CCDC61 | Q9Y6R9 | 369 |
| ZNF461 | HEATR4 | Q86WZ0 | 357 |
| ZNF461 | MSH3 | P20585 | 353 |
| ZNF461 | EPHB2 | P29323 | 352 |
| ZNF461 | MSH6 | P52701 | 351 |
| ZNF461 | PGCKA1 | Q8IY42 | 348 |
| ZNF461 | JRKL | Q9Y4A0 | 312 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF461 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF461 | MDFI | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDEL1 | ZNF461 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MDFI | ZNF461 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF461 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): KRTAP10-3 (Two-hybrid), ZNF461 (Affinity Capture-RNA), ZNF461 (Synthetic Lethality), ZNF461 (Two-hybrid), ZNF461 (Affinity Capture-MS), ZNF461 (Affinity Capture-MS), SF1 (Reconstituted Complex), ZNF461 (Reconstituted Complex), HDAC2 (Reconstituted Complex)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 65 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
925 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36658337:T:TA | donor_gain | 1.0000 |
| 19:36664787:C:CC | acceptor_gain | 0.9900 |
| 19:36664803:T:C | acceptor_gain | 0.9900 |
| 19:36664803:T:TC | acceptor_gain | 0.9900 |
| 19:36666684:TCTTA:T | donor_loss | 0.9900 |
| 19:36666685:CTTA:C | donor_loss | 0.9900 |
| 19:36666686:TTA:T | donor_loss | 0.9900 |
| 19:36666687:TA:T | donor_loss | 0.9900 |
| 19:36666689:C:CT | donor_loss | 0.9900 |
| 19:36656528:T:C | acceptor_gain | 0.9800 |
| 19:36664696:A:AC | donor_gain | 0.9800 |
| 19:36664697:C:CC | donor_gain | 0.9800 |
| 19:36664784:TTG:T | acceptor_gain | 0.9800 |
| 19:36666689:CCTT:C | donor_gain | 0.9800 |
| 19:36640039:CAAGT:C | acceptor_gain | 0.9700 |
| 19:36640043:TCTGA:T | acceptor_loss | 0.9700 |
| 19:36640044:C:CC | acceptor_gain | 0.9700 |
| 19:36640044:C:G | acceptor_loss | 0.9700 |
| 19:36640045:T:G | acceptor_loss | 0.9700 |
| 19:36643788:TTATA:T | donor_loss | 0.9700 |
| 19:36643789:TATA:T | donor_loss | 0.9700 |
| 19:36643790:ATAC:A | donor_loss | 0.9700 |
| 19:36643791:TACC:T | donor_loss | 0.9700 |
| 19:36643792:A:AT | donor_loss | 0.9700 |
| 19:36643793:C:G | donor_loss | 0.9700 |
| 19:36643794:C:G | donor_loss | 0.9700 |
| 19:36664785:TG:T | acceptor_gain | 0.9700 |
| 19:36666688:A:AC | donor_gain | 0.9700 |
| 19:36666689:C:CC | donor_gain | 0.9700 |
| 19:36640041:AGT:A | acceptor_gain | 0.9600 |
AlphaMissense
3787 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36639163:A:C | F394L | 0.998 |
| 19:36639163:A:T | F394L | 0.998 |
| 19:36639165:A:G | F394L | 0.998 |
| 19:36639247:A:C | F366L | 0.997 |
| 19:36639247:A:T | F366L | 0.997 |
| 19:36639249:A:G | F366L | 0.997 |
| 19:36638827:A:C | F506L | 0.996 |
| 19:36638827:A:T | F506L | 0.996 |
| 19:36638829:A:G | F506L | 0.996 |
| 19:36638911:A:C | F478L | 0.996 |
| 19:36638911:A:T | F478L | 0.996 |
| 19:36638913:A:G | F478L | 0.996 |
| 19:36638995:A:C | F450L | 0.996 |
| 19:36638995:A:T | F450L | 0.996 |
| 19:36638997:A:G | F450L | 0.996 |
| 19:36639415:A:C | F310L | 0.996 |
| 19:36639415:A:T | F310L | 0.996 |
| 19:36639417:A:G | F310L | 0.996 |
| 19:36639331:A:C | F338L | 0.995 |
| 19:36639331:A:T | F338L | 0.995 |
| 19:36639333:A:G | F338L | 0.995 |
| 19:36639079:A:C | F422L | 0.994 |
| 19:36639079:A:T | F422L | 0.994 |
| 19:36639081:A:G | F422L | 0.994 |
| 19:36639230:A:G | L372P | 0.994 |
| 19:36638884:A:C | H487Q | 0.993 |
| 19:36638884:A:T | H487Q | 0.993 |
| 19:36638966:T:G | Q460P | 0.993 |
| 19:36638882:T:G | Q488P | 0.992 |
| 19:36639218:T:G | Q376P | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000128174 (19:36658633 C>A,T), RS1000169302 (19:36647624 T>G), RS1000238237 (19:36650713 A>G), RS1000317511 (19:36643973 C>T), RS1000389340 (19:36655277 T>C), RS1000441906 (19:36655655 C>T), RS1000521944 (19:36636588 G>A), RS1000626169 (19:36648137 C>T), RS1000668552 (19:36653609 G>A,C), RS1000693327 (19:36651187 C>T), RS1000942246 (19:36664619 A>G), RS1001091083 (19:36657007 C>T), RS1001112354 (19:36667292 CG>C), RS1001123516 (19:36667598 A>C), RS1001125197 (19:36656742 G>A)
Disease associations
OMIM: gene MIM:608640 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| mono-(2-ethylhexyl)phthalate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Colforsin | decreases reaction, increases expression | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Triiodothyronine | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.